Eupraxia Pharmaceuticals (EPRX) Depreciation & Amortization (CF) (2023 - 2026)
Eupraxia Pharmaceuticals' Depreciation & Amortization (CF) was $72,806 in Q4 2025, up 33.6% from $54,512 a year earlier and up 15.6% from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Depreciation & Amortization (CF) (2023 - 2026) Analysis & Trends
For FY2025, Depreciation & Amortization (CF) at Eupraxia Pharmaceuticals came in at $237,717, up 38.4% from FY2024.
- Depreciation & Amortization (CF) has now increased for three consecutive years, with a three-year compound annual growth rate of 17.1% (FY2022 to FY2025).
- In earlier years, Depreciation & Amortization (CF) was $171,719 in FY2024 (+10.4%), $155,527 in FY2023 (+5.2%) and $147,894 in FY2022.
- The Q4 2025 figure marks the highest quarterly Depreciation & Amortization (CF) in data going back to Q1 2023.
- Compared with a year earlier, Depreciation & Amortization (CF) has increased for five straight quarters, with growth averaging 24.5% over the last eight quarters.
- The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q3 2025 (growth of 66.8%); the worst was Q3 2024 (a decline of 2.5%).
- Per Business Quant data, EPRX's Depreciation & Amortization (CF) in the three quarters before Q4 2025 was $62,993 (Q3 2025), $55,431 (Q2 2025) and $46,487 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 545.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.12 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 192.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 726.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.61 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.12 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 132.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.58 Bn |
| 10 | Eupraxia Pharmaceuticals | 304.87 Mn | -174.66 Mn | - | 183,656.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 183,656.00 |
| Dec 31, 2025 | 72,806.00 |
| Sep 30, 2025 | 62,993.00 |
| Jun 30, 2025 | 55,431.00 |
| Mar 31, 2025 | 46,487.00 |
| Dec 31, 2024 | 54,512.00 |
| Sep 30, 2024 | 37,759.00 |
| Jun 30, 2024 | 42,030.00 |
| Mar 31, 2024 | 37,418.00 |
| Dec 31, 2023 | 41,233.00 |
| Sep 30, 2023 | 38,716.00 |
| Jun 30, 2023 | 38,122.00 |
| Mar 31, 2023 | 37,456.00 |
API Access
Eupraxia Pharmaceuticals Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();